首页 > 最新文献

Revista alergia Mexico最新文献

英文 中文
[Vitamin D and respiratory allergy: state of the art]. [维生素D和呼吸道过敏:最新进展]。
Q3 Medicine Pub Date : 2022-01-01 DOI: 10.29262/ram.v69iSupl1.1033
Daniela Rivero-Yeverino, Aída Inés López-García, Chrystopherson Gengyny Caballero-López, Juan Jesús Ríos-López, José Sergio Papaqui-Tapia, Elisa Elisa Ortega-Jordá Rodríguez, Armando Álvarez-Rivera, Dulce Mariel Ruiz-Sánchez, Edgar Flores-Gonzaga

An increasing number of studies are analyzing the relationship between serum vitamin D levels and the development of sensitization and allergic diseases in genetically predisposed individuals, as well as the impact of vitamin D supplementation. This article reviews the literature on this subject. Clinical trials, meta-analyses and systematic reviews consulted in PubMed, EMBASE, Scopus, Ovid, Wiley Online Library, Springer, Cochrane and manual resources were included, with the keywords: vitamin D, 25 hydroxyvitamin D, cholecalciferol, asthma, rhinitis, allergy, 25-OH-D, 1,25 hydroxyvitamin D, supplementation. The results show a positive linear trend, however, differ. We should keep in mind that in the studies there is heterogeneity of population groups and associated factors, which may modify such studies. It is necessary to increase research to clarify this relationship and to have successful interventions from the patient's approach to the strengthening of pharmacological and immunological treatment of allergic patients with these diseases.

越来越多的研究正在分析血清维生素D水平与遗传易感个体致敏和过敏性疾病发展之间的关系,以及维生素D补充的影响。本文对这方面的文献进行了综述。纳入PubMed、EMBASE、Scopus、Ovid、Wiley Online Library、Springer、Cochrane和手工资源的临床试验、荟萃分析和系统评价,关键词:维生素D、25羟基维生素D、胆钙化醇、哮喘、鼻炎、过敏、25- oh -D、1,25羟基维生素D、补充。结果显示出正线性趋势,但存在差异。我们应该记住,在研究中存在人口群体和相关因素的异质性,这可能会改变这些研究。有必要增加研究以澄清这种关系,并从患者的角度成功干预,加强对这些疾病的过敏患者的药理和免疫治疗。
{"title":"[Vitamin D and respiratory allergy: state of the art].","authors":"Daniela Rivero-Yeverino,&nbsp;Aída Inés López-García,&nbsp;Chrystopherson Gengyny Caballero-López,&nbsp;Juan Jesús Ríos-López,&nbsp;José Sergio Papaqui-Tapia,&nbsp;Elisa Elisa Ortega-Jordá Rodríguez,&nbsp;Armando Álvarez-Rivera,&nbsp;Dulce Mariel Ruiz-Sánchez,&nbsp;Edgar Flores-Gonzaga","doi":"10.29262/ram.v69iSupl1.1033","DOIUrl":"https://doi.org/10.29262/ram.v69iSupl1.1033","url":null,"abstract":"<p><p>An increasing number of studies are analyzing the relationship between serum vitamin D levels and the development of sensitization and allergic diseases in genetically predisposed individuals, as well as the impact of vitamin D supplementation. This article reviews the literature on this subject. Clinical trials, meta-analyses and systematic reviews consulted in PubMed, EMBASE, Scopus, Ovid, Wiley Online Library, Springer, Cochrane and manual resources were included, with the keywords: vitamin D, 25 hydroxyvitamin D, cholecalciferol, asthma, rhinitis, allergy, 25-OH-D, 1,25 hydroxyvitamin D, supplementation. The results show a positive linear trend, however, differ. We should keep in mind that in the studies there is heterogeneity of population groups and associated factors, which may modify such studies. It is necessary to increase research to clarify this relationship and to have successful interventions from the patient's approach to the strengthening of pharmacological and immunological treatment of allergic patients with these diseases.</p>","PeriodicalId":21175,"journal":{"name":"Revista alergia Mexico","volume":"69 Suppl 1 ","pages":"s46-s54"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39657051","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
[Latex allergy: therapeutic options]. [乳胶过敏:治疗选择]。
Q3 Medicine Pub Date : 2022-01-01 DOI: 10.29262/ram.v69iSupl1.1035
Claudia Elizabeth Jiménez-Carrillo, Karen Miroslava Piña-Ramos, Carolina Meza-Arrayales, Kathya Pamela Villaruel-Flores, Alejandro García-Aguirre

Latex allergy is a major problem worldwide due to both the severity of the symptomatology it produces and the risk groups that are exposed to it. Complete avoidance is difficult, if not impossible, due to its ubiquity. Natural rubber latex (NRL) is a natural polymer that is released by the Hevea brasiliensis (Hev b) tree, which functions as a protective sealant. It is currently used for the manufacture of health-care products such as tube caps, pistons, masks, and cannulas. The purpose of this review is to highlight the epidemiological, clinical, and diagnostic aspects of NRL allergy, and to conduct a review of the literature on its management through a bibliographic search of articles in databases such as PubMed, Cochrane, UpToDate, and Google Scholar, up to September 2021. About 121 articles were reviewed, of which 76 were used as a reference. We concluded that latex allergy is an entity for which its treatment, even nowadays, is avoidance, despite having a worldwide prevalence of 4.3 % and representing a surgical complication in about 20 % of surgeries with an anaphylactic reaction and a mortality rate that can reach 9 %. The only treatment that could modify the evolution of this disease is immunotherapy, but there are no standardized extracts yet and it has not been possible to determine the safest and most effective way to apply it.

乳胶过敏是世界范围内的一个主要问题,因为它产生的症状的严重性和暴露于它的风险群体。由于其无处不在,完全避免是困难的,如果不是不可能的话。天然胶乳(NRL)是一种天然聚合物,由巴西橡胶树(Hevea brasiliensis, Hev b)树释放,具有保护密封的功能。它目前用于制造医疗保健产品,如管帽、活塞、口罩和套管。本综述的目的是强调NRL过敏的流行病学、临床和诊断方面,并通过对PubMed、Cochrane、UpToDate和Google Scholar等数据库中截至2021年9月的文章进行书目检索,对其管理方面的文献进行综述。共评审121篇文章,其中76篇作为参考文献。我们的结论是乳胶过敏是一个实体,即使在今天,它的治疗是避免的,尽管在世界范围内有4.3%的患病率,并且在大约20%的手术中出现了外科并发症,伴有过敏反应,死亡率可达到9%。唯一可以改变这种疾病演变的治疗方法是免疫疗法,但目前还没有标准化的提取物,也不可能确定最安全、最有效的应用方法。
{"title":"[Latex allergy: therapeutic options].","authors":"Claudia Elizabeth Jiménez-Carrillo,&nbsp;Karen Miroslava Piña-Ramos,&nbsp;Carolina Meza-Arrayales,&nbsp;Kathya Pamela Villaruel-Flores,&nbsp;Alejandro García-Aguirre","doi":"10.29262/ram.v69iSupl1.1035","DOIUrl":"https://doi.org/10.29262/ram.v69iSupl1.1035","url":null,"abstract":"<p><p>Latex allergy is a major problem worldwide due to both the severity of the symptomatology it produces and the risk groups that are exposed to it. Complete avoidance is difficult, if not impossible, due to its ubiquity. Natural rubber latex (NRL) is a natural polymer that is released by the Hevea brasiliensis (Hev b) tree, which functions as a protective sealant. It is currently used for the manufacture of health-care products such as tube caps, pistons, masks, and cannulas. The purpose of this review is to highlight the epidemiological, clinical, and diagnostic aspects of NRL allergy, and to conduct a review of the literature on its management through a bibliographic search of articles in databases such as PubMed, Cochrane, UpToDate, and Google Scholar, up to September 2021. About 121 articles were reviewed, of which 76 were used as a reference. We concluded that latex allergy is an entity for which its treatment, even nowadays, is avoidance, despite having a worldwide prevalence of 4.3 % and representing a surgical complication in about 20 % of surgeries with an anaphylactic reaction and a mortality rate that can reach 9 %. The only treatment that could modify the evolution of this disease is immunotherapy, but there are no standardized extracts yet and it has not been possible to determine the safest and most effective way to apply it.</p>","PeriodicalId":21175,"journal":{"name":"Revista alergia Mexico","volume":"69 Suppl 1 ","pages":"s55-s68"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39657052","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Latex allergy: a review on the most important aspects]. [乳胶过敏:对最重要方面的回顾]。
Q3 Medicine Pub Date : 2022-01-01 DOI: 10.29262/ram.v69iSupl1.1012
Sandra Nora González-Díaz, Alejandra Macías-Weinmann, Maricela Hernández-Robles, Natalhie Acuña-Ortega Acuña-Ortega

This allergy is a hypersensitivity reaction that is triggered by contact with latex. Symptoms vary depending on factors such as route, frequency, and exposure dose, as well as individual susceptibility. The clinical manifestations can be localized at the site of contact with latex or generalized. Exposure can occur directly as a result of contact with the skin and mucous membranes, that is by touching or being touched by objects with latex, or by inhaling (breathing) particles from objects with latex. Contact can also be indirect; for example, by ingesting food that has been handled by a worker wearing latex gloves or by having contact with a person who has been blowing up balloons. The diagnosis of latex allergy is made based on the patient's medical history and on what has been reported in the interrogation, and it is complemented with in vivo studies (such as skin tests and provocation tests) or in vitro studies (determination of specific IgE). The fundamental pillar in the treatment of latex allergy is the education of the patient to achieve the avoidance of products made with this material or the contact and intake of food that has had contact with latex. In view of the foregoing, latex allergy has a great medical and social relevance due to all the safety measures that the patient must take.

这种过敏是一种由接触乳胶引起的超敏反应。症状因途径、频率、暴露剂量以及个体易感性等因素而异。临床表现可局限于接触乳胶的部位,也可普遍化。接触皮肤和粘膜可直接发生暴露,即通过触摸或被带有乳胶的物体触摸,或通过从带有乳胶的物体吸入(呼吸)颗粒。接触也可以是间接的;例如,摄入了戴着乳胶手套的工人处理过的食物,或者与正在吹气球的人接触过。乳胶过敏的诊断是根据病人的病史和审讯中报告的情况作出的,并辅以体内研究(如皮肤试验和刺激试验)或体外研究(测定特定的IgE)。乳胶过敏治疗的基本支柱是教育患者避免使用这种材料制成的产品或接触和摄入与乳胶有接触的食物。鉴于上述情况,由于患者必须采取的所有安全措施,乳胶过敏具有很大的医学和社会相关性。
{"title":"[Latex allergy: a review on the most important aspects].","authors":"Sandra Nora González-Díaz,&nbsp;Alejandra Macías-Weinmann,&nbsp;Maricela Hernández-Robles,&nbsp;Natalhie Acuña-Ortega Acuña-Ortega","doi":"10.29262/ram.v69iSupl1.1012","DOIUrl":"https://doi.org/10.29262/ram.v69iSupl1.1012","url":null,"abstract":"<p><p>This allergy is a hypersensitivity reaction that is triggered by contact with latex. Symptoms vary depending on factors such as route, frequency, and exposure dose, as well as individual susceptibility. The clinical manifestations can be localized at the site of contact with latex or generalized. Exposure can occur directly as a result of contact with the skin and mucous membranes, that is by touching or being touched by objects with latex, or by inhaling (breathing) particles from objects with latex. Contact can also be indirect; for example, by ingesting food that has been handled by a worker wearing latex gloves or by having contact with a person who has been blowing up balloons. The diagnosis of latex allergy is made based on the patient's medical history and on what has been reported in the interrogation, and it is complemented with in vivo studies (such as skin tests and provocation tests) or in vitro studies (determination of specific IgE). The fundamental pillar in the treatment of latex allergy is the education of the patient to achieve the avoidance of products made with this material or the contact and intake of food that has had contact with latex. In view of the foregoing, latex allergy has a great medical and social relevance due to all the safety measures that the patient must take.</p>","PeriodicalId":21175,"journal":{"name":"Revista alergia Mexico","volume":"69 Suppl 1 ","pages":"s31-s37"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39657049","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Asthma and COVID-19]. [哮喘和COVID-19]。
Q3 Medicine Pub Date : 2022-01-01 DOI: 10.29262/ram.v69iSupl1.1009
José Jesús López-Tiro, Elvia Angélica Contreras-Contreras, Nancy Nayeli Cruz-Arellanes, Mario Alberto Camargo-Pirrón, Erick Oswaldo Cabrera-Buendía, Guadalupe Isadora Ramírez-Pérez, Guillermo Vega-Acevedo

The COVID-19 pandemic has collapsed the health systems of many countries in the world and comorbidities in adults have exponentially increased their mortality; in matters of asthma, it has not been possible to establish a defining relationship in mortality. The clinical manifestations of asthmatic patients with SARS COV 2 are presented in a wide range; from asymptomatic to those who experience acute respiratory failure. The most sensitive method for the diagnosis of SARS-CoV-2 infection is RT-PCR. Antigen and serologic tests are quicker than RT-PCR, but they are less sensitive. Radiologic studies and the computed tomography of the chest assist in the diagnosis and follow-up of SARS-CoV-2 infection. The use of spirometry for diagnosis and follow-up is restricted due to the elevated risk of contagion. It has been shown that eosinophilia and TH2 inflammation, due to their antiviral immune effect, are protective factors against severe SARS-CoV-2/COVID-19. Patients with mild asthma express less angiotensin converting enzyme receptors (ACE2), and those with neutrophilic asthma express it in greater proportion, which suggests more severe presentations of COVID-19. The conventional asthma treatment modulates the SARS-CoV-2/COVID-19 immune response, which is why patients with controlled asthma have non-severe manifestations of COVID 19, however, the mechanisms are not clear.

COVID-19大流行使世界上许多国家的卫生系统崩溃,成人的合并症使其死亡率呈指数增长;在哮喘方面,还不可能确定死亡率之间的关系。SARS冠状病毒2型哮喘患者的临床表现具有广泛性;从无症状到出现急性呼吸衰竭。RT-PCR是诊断SARS-CoV-2感染最敏感的方法。抗原和血清学测试比RT-PCR更快,但灵敏度较低。胸部放射学研究和计算机断层扫描有助于诊断和随访SARS-CoV-2感染。由于感染风险升高,限制了肺活量测定用于诊断和随访。研究表明,嗜酸性粒细胞和TH2炎症由于其抗病毒免疫作用,是对抗严重的SARS-CoV-2/COVID-19的保护因素。轻度哮喘患者血管紧张素转换酶受体(ACE2)表达较少,中性粒细胞哮喘患者表达比例更高,这表明COVID-19的症状更严重。常规哮喘治疗可调节SARS-CoV-2/COVID-19的免疫反应,这是控制哮喘患者出现非严重COVID-19表现的原因,但其机制尚不清楚。
{"title":"[Asthma and COVID-19].","authors":"José Jesús López-Tiro,&nbsp;Elvia Angélica Contreras-Contreras,&nbsp;Nancy Nayeli Cruz-Arellanes,&nbsp;Mario Alberto Camargo-Pirrón,&nbsp;Erick Oswaldo Cabrera-Buendía,&nbsp;Guadalupe Isadora Ramírez-Pérez,&nbsp;Guillermo Vega-Acevedo","doi":"10.29262/ram.v69iSupl1.1009","DOIUrl":"https://doi.org/10.29262/ram.v69iSupl1.1009","url":null,"abstract":"<p><p>The COVID-19 pandemic has collapsed the health systems of many countries in the world and comorbidities in adults have exponentially increased their mortality; in matters of asthma, it has not been possible to establish a defining relationship in mortality. The clinical manifestations of asthmatic patients with SARS COV 2 are presented in a wide range; from asymptomatic to those who experience acute respiratory failure. The most sensitive method for the diagnosis of SARS-CoV-2 infection is RT-PCR. Antigen and serologic tests are quicker than RT-PCR, but they are less sensitive. Radiologic studies and the computed tomography of the chest assist in the diagnosis and follow-up of SARS-CoV-2 infection. The use of spirometry for diagnosis and follow-up is restricted due to the elevated risk of contagion. It has been shown that eosinophilia and TH2 inflammation, due to their antiviral immune effect, are protective factors against severe SARS-CoV-2/COVID-19. Patients with mild asthma express less angiotensin converting enzyme receptors (ACE2), and those with neutrophilic asthma express it in greater proportion, which suggests more severe presentations of COVID-19. The conventional asthma treatment modulates the SARS-CoV-2/COVID-19 immune response, which is why patients with controlled asthma have non-severe manifestations of COVID 19, however, the mechanisms are not clear.</p>","PeriodicalId":21175,"journal":{"name":"Revista alergia Mexico","volume":"69 Suppl 1 ","pages":"s15-s23"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39798202","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Environmental pollution and allergy]. 【环境污染与过敏】。
Q3 Medicine Pub Date : 2022-01-01 DOI: 10.29262/ram.v69iSupl1.1010
Sandra Nora González-Díaz, Cindy Elizabeth de Lira-Quezada, Rosalaura Virginia Villarreal-González, José Ignacio Canseco-Villarreal
La contaminación del aire, el cambio climático y la reducción de la diversidad biológica son amenazas importantes para la salud humana. En las últimas décadas se ha observado un aumento en las enfermedades alérgicas incluyendo asma y rinoconjuntivitis. Hasta al 40% de la población mundial pueden presentar alguna enfermedad alérgica representando un impacto significativo en la calidad de vida de quienes la padecen, siendo la contaminación ambiental una de las causas de su presentación. La contaminación del aire causa morbilidad y mortalidad significativas en pacientes con enfermedades inflamatorias de las vías respiratorias como rinitis alérgica, rinosinusitis crónica, asma y enfermedad pulmonar obstructiva crónica. El estrés oxidativo en pacientes con enfermedades respiratorias puede inducir inflamación eosinofílica en las vías respiratorias, aumentar la sensibilización alérgica atópica y aumentar la susceptibilidad a infecciones. El cambio climático ha influido en la exposición a alérgenos extramuros y se asocia con exacerbaciones de enfermedades de la vía respiratoria superior e inferior. La interacción de las exposiciones ambientales en interiores y exteriores y los factores del huésped pueden afectar el desarrollo y la progresión de enfermedades alérgicas de por vida. La reducción de la exposición a los contaminantes del aire se ha asociado con una respuesta favorable en la salud respiratoria por lo cual es necesario implementar medidas que contribuyan a la mejoría en la calidad del aire.
空气污染、气候变化和生物多样性减少是对人类健康的主要威胁。在过去的几十年里,已经观察到过敏性疾病的增加,包括哮喘和鼻结膜炎。高达40%的世界人口可能患有过敏性疾病,这对患者的生活质量产生了重大影响,而环境污染是其表现的原因之一。空气污染导致过敏性鼻炎、慢性鼻窦炎、哮喘和慢性阻塞性肺疾病等炎症性气道疾病患者的显著发病率和死亡率。呼吸系统疾病患者的氧化应激可诱发气道嗜酸性粒细胞炎症,增加特应性过敏致敏,增加感染易感性。气候变化影响了外部过敏原的暴露,并与上呼吸道和下呼吸道疾病的恶化有关。室内外环境暴露与宿主因素的相互作用可影响终身过敏性疾病的发生和进展。减少接触空气污染物与呼吸道健康的良好反应有关,这就是为什么有必要采取有助于改善空气质量的措施。
{"title":"[Environmental pollution and allergy].","authors":"Sandra Nora González-Díaz,&nbsp;Cindy Elizabeth de Lira-Quezada,&nbsp;Rosalaura Virginia Villarreal-González,&nbsp;José Ignacio Canseco-Villarreal","doi":"10.29262/ram.v69iSupl1.1010","DOIUrl":"https://doi.org/10.29262/ram.v69iSupl1.1010","url":null,"abstract":"La contaminación del aire, el cambio climático y la reducción de la diversidad biológica son amenazas importantes para la salud humana. En las últimas décadas se ha observado un aumento en las enfermedades alérgicas incluyendo asma y rinoconjuntivitis. Hasta al 40% de la población mundial pueden presentar alguna enfermedad alérgica representando un impacto significativo en la calidad de vida de quienes la padecen, siendo la contaminación ambiental una de las causas de su presentación. La contaminación del aire causa morbilidad y mortalidad significativas en pacientes con enfermedades inflamatorias de las vías respiratorias como rinitis alérgica, rinosinusitis crónica, asma y enfermedad pulmonar obstructiva crónica. El estrés oxidativo en pacientes con enfermedades respiratorias puede inducir inflamación eosinofílica en las vías respiratorias, aumentar la sensibilización alérgica atópica y aumentar la susceptibilidad a infecciones. El cambio climático ha influido en la exposición a alérgenos extramuros y se asocia con exacerbaciones de enfermedades de la vía respiratoria superior e inferior. La interacción de las exposiciones ambientales en interiores y exteriores y los factores del huésped pueden afectar el desarrollo y la progresión de enfermedades alérgicas de por vida. La reducción de la exposición a los contaminantes del aire se ha asociado con una respuesta favorable en la salud respiratoria por lo cual es necesario implementar medidas que contribuyan a la mejoría en la calidad del aire.","PeriodicalId":21175,"journal":{"name":"Revista alergia Mexico","volume":"69 Suppl 1 ","pages":"s24-s30"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39798203","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
[Pollen-food syndrom. A rewiev with a twist]. [Pollen-food症侯群。有转折的重审]。
Q3 Medicine Pub Date : 2022-01-01 DOI: 10.29262/ram.v69iSupl1.1018
Patricia María O Farrill-Romanillos, José Efraín Bermúdez-Márquez, Edwin Daniel Maldonado-Domínguez, Nancy Valeria López-Moreno, Juan José Reyes-Aguilar, Karen Lilian Rivera-Alvarado, Silvia Paulina Ruiz-López, Diana Andrea Herrera-Sánchez

Pollen-food syndrome (PFS) is characterized by allergic sensitization to proteins of pollens of grasses, weeds, and trees, which produce a type I hypersensitivity reaction that is associated with the intake of plant-derived foods that are usually in raw form. The most frequently-associated protein families are: profilins, PR-10, and ns LTP; however, others such as thaumatins, isoflavones, reductases, and B1,2 glucanases have been documented. The prototype syndrome is birch-fruit-vegetables, and of these, the most common is birch-apple due to the fact that more than 70 % of patients who are sensitized to birch present symptoms associated with the intake of plant-derived foods. The symptoms are restricted to the oral cavity; however, some patients may present systemic symptoms, including anaphylaxis, so it is important to identify the type of protein that is involved since the type of reaction that the patient may present depends on that. In spite of everything, it is considered an entity that may be under diagnosed due to its complex diagnosis and treatment, since the procedure, in most cases, is an elimination diet, because treatment with immunotherapy is not yet available. The purpose of this review is to describe the pathophysiology, as well as the most common pollen-food syndromes.

花粉食物综合征(PFS)的特点是对草、杂草和树木的花粉蛋白质过敏,产生I型超敏反应,这与摄入通常以生形式存在的植物性食物有关。最常见的相关蛋白家族有:profilins、PR-10和ns LTP;然而,其他如异黄素、异黄酮、还原酶和B1,2葡聚糖酶已被记录。原型综合征是桦树水果蔬菜,其中,最常见的是桦树苹果,因为超过70%的对桦树过敏的患者表现出与摄入植物性食物相关的症状。症状局限于口腔;然而,一些患者可能会出现全身性症状,包括过敏反应,因此确定所涉及的蛋白质类型是很重要的,因为患者可能出现的反应类型取决于蛋白质类型。尽管如此,由于其复杂的诊断和治疗,它被认为是一种可能被诊断不足的实体,因为在大多数情况下,手术是一种消除饮食,因为免疫疗法的治疗尚不可用。本文的目的是描述病理生理,以及最常见的花粉食物综合征。
{"title":"[Pollen-food syndrom. A rewiev with a twist].","authors":"Patricia María O Farrill-Romanillos,&nbsp;José Efraín Bermúdez-Márquez,&nbsp;Edwin Daniel Maldonado-Domínguez,&nbsp;Nancy Valeria López-Moreno,&nbsp;Juan José Reyes-Aguilar,&nbsp;Karen Lilian Rivera-Alvarado,&nbsp;Silvia Paulina Ruiz-López,&nbsp;Diana Andrea Herrera-Sánchez","doi":"10.29262/ram.v69iSupl1.1018","DOIUrl":"https://doi.org/10.29262/ram.v69iSupl1.1018","url":null,"abstract":"<p><p>Pollen-food syndrome (PFS) is characterized by allergic sensitization to proteins of pollens of grasses, weeds, and trees, which produce a type I hypersensitivity reaction that is associated with the intake of plant-derived foods that are usually in raw form. The most frequently-associated protein families are: profilins, PR-10, and ns LTP; however, others such as thaumatins, isoflavones, reductases, and B1,2 glucanases have been documented. The prototype syndrome is birch-fruit-vegetables, and of these, the most common is birch-apple due to the fact that more than 70 % of patients who are sensitized to birch present symptoms associated with the intake of plant-derived foods. The symptoms are restricted to the oral cavity; however, some patients may present systemic symptoms, including anaphylaxis, so it is important to identify the type of protein that is involved since the type of reaction that the patient may present depends on that. In spite of everything, it is considered an entity that may be under diagnosed due to its complex diagnosis and treatment, since the procedure, in most cases, is an elimination diet, because treatment with immunotherapy is not yet available. The purpose of this review is to describe the pathophysiology, as well as the most common pollen-food syndromes.</p>","PeriodicalId":21175,"journal":{"name":"Revista alergia Mexico","volume":"69 Suppl 1 ","pages":"s38-s45"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39657050","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Anaphylaxis caused by vaccines]. [疫苗引起的过敏反应]。
Q3 Medicine Pub Date : 2022-01-01 DOI: 10.29262/ram.v69iSupl1.989
Pablo Perea-Valle, Carlos Julio Delgado-Aguirre, Belkis Grindeli Villafuerte-Domínguez, Blanca Estela Del Río-Navarro

Even though the SARS-CoV-2 pandemic represents a historical challenge, science has had an exponential development, and the current vaccination campaigns are proof of this. Unfortunately, along came misinformation and myths regarding their production and their adverse effects. For this reason, we have considered of utter importance to review anaphylaxis, one of the most feared vaccine adverse events.Anaphylaxis can be defined as a life-threatening acute and systemic allergic reaction, with a wide clinical spectrum, which can be explained by many immunological mechanisms, and whose diagnostic complexity demands the fulfillment of strict criteria. Though infrequent, any vaccine has the potential to trigger anaphylaxis. In the United States, for the new SARS-CoV-2 vaccines, rates from 1:200 000 (Pfizer-BioNTech) to 1:360 000 doses (Moderna) have been estimated. Vaccine adverse events can be mediated by hypersensitivity reactions, either allergic or not. Unlike a typical drug allergy, rarely is the active ingredient responsible for the reaction. Therefore, excipients must be considered during the approach to this problem. Vaccine associated anaphylaxis has to be referred to an allergist so as to guarantee the maximum benefit for the patient and improve the vaccines' security profile.

尽管SARS-CoV-2大流行是一个历史性的挑战,但科学已经取得了指数级的发展,目前的疫苗接种运动就是证明。不幸的是,随之而来的是关于它们的生产及其不利影响的错误信息和神话。因此,我们认为回顾过敏反应是非常重要的,这是最可怕的疫苗不良事件之一。过敏反应是一种危及生命的急性全身性过敏反应,具有广泛的临床谱,可以用许多免疫机制来解释,其诊断的复杂性要求满足严格的标准。虽然不常见,但任何疫苗都有可能引发过敏反应。在美国,对于新的SARS-CoV-2疫苗,估计比率从1:20万(辉瑞- biontech)到1:36万剂量(Moderna)。疫苗不良反应可由过敏或非过敏的超敏反应介导。不像典型的药物过敏,很少是活性成分负责的反应。因此,在处理这个问题时必须考虑辅料。疫苗相关的过敏反应必须提交给过敏专科医生,以保证患者的最大利益,并提高疫苗的安全性。
{"title":"[Anaphylaxis caused by vaccines].","authors":"Pablo Perea-Valle,&nbsp;Carlos Julio Delgado-Aguirre,&nbsp;Belkis Grindeli Villafuerte-Domínguez,&nbsp;Blanca Estela Del Río-Navarro","doi":"10.29262/ram.v69iSupl1.989","DOIUrl":"https://doi.org/10.29262/ram.v69iSupl1.989","url":null,"abstract":"<p><p>Even though the SARS-CoV-2 pandemic represents a historical challenge, science has had an exponential development, and the current vaccination campaigns are proof of this. Unfortunately, along came misinformation and myths regarding their production and their adverse effects. For this reason, we have considered of utter importance to review anaphylaxis, one of the most feared vaccine adverse events.Anaphylaxis can be defined as a life-threatening acute and systemic allergic reaction, with a wide clinical spectrum, which can be explained by many immunological mechanisms, and whose diagnostic complexity demands the fulfillment of strict criteria. Though infrequent, any vaccine has the potential to trigger anaphylaxis. In the United States, for the new SARS-CoV-2 vaccines, rates from 1:200 000 (Pfizer-BioNTech) to 1:360 000 doses (Moderna) have been estimated. Vaccine adverse events can be mediated by hypersensitivity reactions, either allergic or not. Unlike a typical drug allergy, rarely is the active ingredient responsible for the reaction. Therefore, excipients must be considered during the approach to this problem. Vaccine associated anaphylaxis has to be referred to an allergist so as to guarantee the maximum benefit for the patient and improve the vaccines' security profile.</p>","PeriodicalId":21175,"journal":{"name":"Revista alergia Mexico","volume":"69 Suppl 1 ","pages":"s1-s14"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39798201","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
[The diagnostic approach to difficult-to-treat asthma and severe asthma]. [难治性哮喘和重度哮喘的诊断方法]。
Q3 Medicine Pub Date : 2022-01-01 DOI: 10.29262/ram.v69iSupl1.1046
Marco Venancio-Hernández, Elizabeth Mendieta-Flores, Jeannette Mendiola-Marín, Angélica Kathya Alaniz-Flores, Mireya Reyes-Arellano

Difficult-to-treat asthma refers to asthma that is not controlled despite high or medium doses of inhaled steroids or in which high doses of treatment are required to maintain an adequate control of the symptoms and to reduce the risk of exacerbations. An inadequate technique to use the inhaler, poor adherence to treatment, smoking, comorbidities, or an incorrect diagnosis should be considered. In severe asthma, despite adherence to treatment with optimized maximum doses and the management of factors that could contribute, multiple medications in maximum doses are required to have an adequate therapeutic control or this is not achieved. The approach to these patients involves a meticulous process due to the multiple factors that can influence poor asthma control and that can lead to a misclassification of the disease when, in reality, the patient can be presenting different comorbidities whose treatment could decrease the severity of asthma symptoms and modify the prognosis. The objective of this document is to make the approach to patients with difficult-to-treat asthma and severe asthma known, as well as the most frequent comorbidities. A search was made in PubMed with the purpose of identifying the main pathologies that may be present in patients and, based on what is described in the literature, to propose a diagnostic approach. 100 studies were comprised in this review, including clinical guidelines such as GINA, GEMA, and ERS/ATS.

难治性哮喘是指尽管吸入高剂量或中剂量类固醇仍无法控制的哮喘,或需要高剂量治疗以维持对症状的适当控制并减少恶化风险的哮喘。应考虑吸入器使用技术不充分、治疗依从性差、吸烟、合并症或错误诊断。在严重哮喘中,尽管坚持使用最佳最大剂量治疗并对可能起作用的因素进行了管理,但仍需要使用最大剂量的多种药物才能获得充分的治疗控制,否则无法实现。对这些患者的治疗涉及一个细致的过程,因为影响哮喘控制不良的多种因素可能导致疾病的错误分类,而实际上,患者可能出现不同的合并症,其治疗可能会降低哮喘症状的严重程度并改变预后。本文件的目的是使难以治疗的哮喘和严重哮喘患者以及最常见的合并症的方法为人所知。在PubMed上进行了一项搜索,目的是确定患者可能出现的主要病理,并根据文献中描述的内容提出一种诊断方法。本综述纳入了100项研究,包括临床指南,如GINA、GEMA和ERS/ATS。
{"title":"[The diagnostic approach to difficult-to-treat asthma and severe asthma].","authors":"Marco Venancio-Hernández,&nbsp;Elizabeth Mendieta-Flores,&nbsp;Jeannette Mendiola-Marín,&nbsp;Angélica Kathya Alaniz-Flores,&nbsp;Mireya Reyes-Arellano","doi":"10.29262/ram.v69iSupl1.1046","DOIUrl":"https://doi.org/10.29262/ram.v69iSupl1.1046","url":null,"abstract":"<p><p>Difficult-to-treat asthma refers to asthma that is not controlled despite high or medium doses of inhaled steroids or in which high doses of treatment are required to maintain an adequate control of the symptoms and to reduce the risk of exacerbations. An inadequate technique to use the inhaler, poor adherence to treatment, smoking, comorbidities, or an incorrect diagnosis should be considered. In severe asthma, despite adherence to treatment with optimized maximum doses and the management of factors that could contribute, multiple medications in maximum doses are required to have an adequate therapeutic control or this is not achieved. The approach to these patients involves a meticulous process due to the multiple factors that can influence poor asthma control and that can lead to a misclassification of the disease when, in reality, the patient can be presenting different comorbidities whose treatment could decrease the severity of asthma symptoms and modify the prognosis. The objective of this document is to make the approach to patients with difficult-to-treat asthma and severe asthma known, as well as the most frequent comorbidities. A search was made in PubMed with the purpose of identifying the main pathologies that may be present in patients and, based on what is described in the literature, to propose a diagnostic approach. 100 studies were comprised in this review, including clinical guidelines such as GINA, GEMA, and ERS/ATS.</p>","PeriodicalId":21175,"journal":{"name":"Revista alergia Mexico","volume":"69 Suppl 1 ","pages":"s94-s111"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39657469","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Factors associated with tobacco use in patients with asthma during the confinement due to COVID-19 in an urban region with high numbers of SARS-CoV-2 infections]. [在SARS-CoV-2感染高发的城市地区,COVID-19导致哮喘患者坐月子期间吸烟的相关因素]。
Q3 Medicine Pub Date : 2021-10-01 DOI: 10.29262/ram.v68i4.922
Eliza Mireya Vázquez, Carlos Francisco Vázquez-Rodríguez, Nancy Virginia Ortega-Betancourt, Humberto Martínez-Montoya, Octelina Castillo-Ruiz, Francisco Vázquez-Nava

Objective: To determine the prevalence and risk factors associated with tobacco use during the period of confinement in light of the COVID-19 pandemic.

Methods: Through an analytical and cross-sectional study, the data of 2, 372 participants were analyzed. The information was collected through a self-administered questionnaire that was built with the Google Forms tool, which was distributed and applied via email and WhatsApp; the private messaging platform. The relationship between the independent variables and the outcome was determined by multivariate logistic regression analysis.

Results: Out of the total population, 69.3 % were women, the median age was 20.11±2.01 years, the prevalence of asthma was 12.2 %, and the active tobacco use was 13.3 %. There was a higher number of patients with asthma who smoked (14.2 vs. 13.2 %) than of those who didn't have asthma. The multivariate logistic regression analysis showed that factors like considering that COVID-19 does not exist and not being confined were related to tobacco use in patients with asthma during the implementation of the contingency plan that the COVID-19 pandemic represents.

Conclusions: During confinement to home for COVID-19, the prevalence of tobacco use is higher in patients with asthma than in individuals without this ailment; the factors that favor the aforementioned are present in the family environment.

目的:在2019冠状病毒病大流行背景下,了解禁闭期间吸烟的流行情况及相关危险因素。方法:采用分析和横断面研究的方法,对2372名被试进行数据分析。信息是通过使用Google Forms工具构建的自我管理问卷收集的,该问卷通过电子邮件和WhatsApp分发和应用;私人消息传递平台。通过多变量logistic回归分析确定自变量与结果的关系。结果:患者中女性占69.3%,中位年龄为20.11±2.01岁,哮喘患病率为12.2%,吸烟活跃率为13.3%。哮喘患者中吸烟的比例(14.2%比13.2%)高于非哮喘患者。多因素logistic回归分析显示,在实施以COVID-19大流行为代表的应急预案过程中,不考虑COVID-19不存在、不被限制等因素与哮喘患者的烟草使用有关。结论:在COVID-19隔离期间,哮喘患者的烟草使用率高于无哮喘患者;有利于上述因素存在于家庭环境中。
{"title":"[Factors associated with tobacco use in patients with asthma during the confinement due to COVID-19 in an urban region with high numbers of SARS-CoV-2 infections].","authors":"Eliza Mireya Vázquez,&nbsp;Carlos Francisco Vázquez-Rodríguez,&nbsp;Nancy Virginia Ortega-Betancourt,&nbsp;Humberto Martínez-Montoya,&nbsp;Octelina Castillo-Ruiz,&nbsp;Francisco Vázquez-Nava","doi":"10.29262/ram.v68i4.922","DOIUrl":"https://doi.org/10.29262/ram.v68i4.922","url":null,"abstract":"<p><strong>Objective: </strong>To determine the prevalence and risk factors associated with tobacco use during the period of confinement in light of the COVID-19 pandemic.</p><p><strong>Methods: </strong>Through an analytical and cross-sectional study, the data of 2, 372 participants were analyzed. The information was collected through a self-administered questionnaire that was built with the Google Forms tool, which was distributed and applied via email and WhatsApp; the private messaging platform. The relationship between the independent variables and the outcome was determined by multivariate logistic regression analysis.</p><p><strong>Results: </strong>Out of the total population, 69.3 % were women, the median age was 20.11±2.01 years, the prevalence of asthma was 12.2 %, and the active tobacco use was 13.3 %. There was a higher number of patients with asthma who smoked (14.2 vs. 13.2 %) than of those who didn't have asthma. The multivariate logistic regression analysis showed that factors like considering that COVID-19 does not exist and not being confined were related to tobacco use in patients with asthma during the implementation of the contingency plan that the COVID-19 pandemic represents.</p><p><strong>Conclusions: </strong>During confinement to home for COVID-19, the prevalence of tobacco use is higher in patients with asthma than in individuals without this ailment; the factors that favor the aforementioned are present in the family environment.</p>","PeriodicalId":21175,"journal":{"name":"Revista alergia Mexico","volume":"68 4","pages":"218-224"},"PeriodicalIF":0.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39585752","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Food allergy and its association with self-reported atopic dermatitis in young adults in Lima-Peru]. [食物过敏及其与利马-秘鲁年轻人自我报告的特应性皮炎的关系]。
Q3 Medicine Pub Date : 2021-10-01 DOI: 10.29262/ram.v68i4.851
María José Rojas-Puell, Fernando M Runzer-Colmenares, Danna Salazar-Gastelú, Flor Santa Cruz-De Lama, Alejandra Medina-Hernández

Objective: To specify the association between atopic dermatitis and food allergies in students of Human Medicine in a private university in Lima-Peru.

Methods: An observational, analytical, cross-sectional study that included 355 students of human medicine between the ages of 18 and 25 years, of a private university in Lima-Peru, through a virtual survey. The data were analyzed using Fisher's technique, Student's T test, and Poisson regression.

Results: In a model that was adjusted by age and sex, having atopic dermatitis was associated with 5.53 times the probability of having food allergies (95 % confidence interval, 3.12-9.79).

Conclusions: There was an association between the precedent of atopic dermatitis and reported food allergies in 28.95 % of the students of human medicine of a private university in Lima-Peru.

目的:了解利马-秘鲁某私立大学人类医学专业学生特应性皮炎与食物过敏的关系。方法:通过虚拟调查,对利马-秘鲁一所私立大学355名年龄在18至25岁之间的人类医学学生进行了观察性、分析性、横断面研究。采用Fisher技术、Student’s T检验和泊松回归对数据进行分析。结果:在一个根据年龄和性别调整的模型中,患有特应性皮炎与食物过敏的概率相关5.53倍(95%置信区间,3.12-9.79)。结论:利马-秘鲁一所私立大学人类医学专业28.95%的学生有异位性皮炎病史与食物过敏相关。
{"title":"[Food allergy and its association with self-reported atopic dermatitis in young adults in Lima-Peru].","authors":"María José Rojas-Puell,&nbsp;Fernando M Runzer-Colmenares,&nbsp;Danna Salazar-Gastelú,&nbsp;Flor Santa Cruz-De Lama,&nbsp;Alejandra Medina-Hernández","doi":"10.29262/ram.v68i4.851","DOIUrl":"https://doi.org/10.29262/ram.v68i4.851","url":null,"abstract":"<p><strong>Objective: </strong>To specify the association between atopic dermatitis and food allergies in students of Human Medicine in a private university in Lima-Peru.</p><p><strong>Methods: </strong>An observational, analytical, cross-sectional study that included 355 students of human medicine between the ages of 18 and 25 years, of a private university in Lima-Peru, through a virtual survey. The data were analyzed using Fisher's technique, Student's T test, and Poisson regression.</p><p><strong>Results: </strong>In a model that was adjusted by age and sex, having atopic dermatitis was associated with 5.53 times the probability of having food allergies (95 % confidence interval, 3.12-9.79).</p><p><strong>Conclusions: </strong>There was an association between the precedent of atopic dermatitis and reported food allergies in 28.95 % of the students of human medicine of a private university in Lima-Peru.</p>","PeriodicalId":21175,"journal":{"name":"Revista alergia Mexico","volume":"68 4","pages":"233-241"},"PeriodicalIF":0.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39585755","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Revista alergia Mexico
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1